SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Foder Bio-tech
Foder Bio-tech Spółka z Ograniczoną Odpowiedzialnością w Upadłości
Wyniki finansowe firmy Foder Bio-tech: przychody, zysk netto, rentowność, ROE, marża, wskaźniki inwestorskie i wycena. Dane z oficjalnych sprawozdań KRS (0000536255).
Foder Bio-tech has filed financial statements for 7 reporting years in the Polish National Court Register (KRS 0000536255), covering 2018–2024. The dashboard below shows the income statement, balance sheet, profitability ratios, valuation indicators and a multi-year comparison against the company's industry benchmark.
Headline figures for the most recent reported year (2024): net revenue 14,692,242 PLN, net profit -13,372,599 PLN, total assets 4,693,666 PLN and equity -11,560,078 PLN. Use the chart toolbar to switch between absolute amounts and indexed series, or to jump straight into the per-year sprawozdanie finansowe.
Derived metrics include ROE, ROA, net and operating margin, the current ratio and the cash ratio, debt-to-equity and asset turnover. Each ratio is plotted alongside the median for Foder Bio-tech's PKD activity class, so reading whether the company is above or below the industry takes one glance instead of a side-by-side calculation.
Revenue
14.7 M PLN
2024
Net profit
-13.4 M PLN
2024
Assets
4.7 M PLN
2024
Equity
-11.6 M PLN
2024
EBITDA
-4.6 M PLN
2024
Analysis of financial data across available reporting years
ROA
-284.91%
Negative return on assets
Debt ratio
3.46
High leverage
Asset turnover
3.13
Net margin
-91.02%
ROE
N/A
Current ratio
0.18
Gross margin
-91.02%
Operating margin
-32.08%
Debt / equity
N/A
Working capital
-5.4 M PLN
7 years of data (2018–2024)
Revenue
2024
Net profit
4/7 profitable years
Assets
2024
Equity
Negative!
Net revenue
Net profit / loss
Profit waterfall 2024
Cost structure 2024
Ratios 2024
Full table of ratios over 7 years (2018–2024)
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | -1.06% | 1.24% | 2.82% | 0.32% | -91.02% |
| Operating margin | -0.05% | 0.15% | 3.28% | 0.68% | -32.08% |
| EBIT margin | -0.05% | 0.15% | 3.28% | 0.68% | -32.08% |
| EBITDA margin | 0.54% | 0.43% | 3.48% | 1.06% | -31.02% |
| Net margin | -1.14% | 1.24% | 2.39% | 0.29% | -91.02% |
| ROA | -5.76% | 11.03% | 19.28% | 1.17% | -284.91% |
| ROE | - | 173.59% | 81.18% | 5.90% | - |
| Liquidity | |||||
| Current ratio | 0.95 | 1.11 | 1.17 | 1.23 | 0.18 |
| Quick ratio | 0.42 | 0.41 | 0.39 | 0.60 | 0.18 |
| Cash ratio | 0.09 | 0.09 | 0.07 | 0.03 | 0.00 |
| Working capital | -363.6 K PLN | 517.3 K PLN | 1.2 M PLN | 1.5 M PLN | -5.4 M PLN |
| Working capital / revenue | -0.82% | 0.92% | 1.64% | 3.29% | -36.57% |
| Leverage | |||||
| Equity ratio | -3.39% | 6.36% | 23.75% | 19.87% | -246.29% |
| Debt / assets | 103.39% | 93.64% | 76.25% | 72.90% | 333.29% |
| Debt / equity | - | 14.73 | 3.21 | 3.67 | - |
| Interest coverage (EBIT) | -0.06 | 0.45 | 7.24 | 2.01 | -2.12 |
| Efficiency | |||||
| Asset turnover | 5.07 | 8.87 | 8.07 | 4.03 | 3.13 |
| Fixed assets / revenue | 2.33% | 1.63% | 1.30% | 7.19% | 23.73% |
| Receivables / revenue | 5.71% | 2.75% | 2.99% | 8.04% | 7.67% |
| DSO (days) | 21 | 10 | 11 | 29 | 28 |
| Inventory days | 36 | 22 | 28 | 33 | 0 |
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Foder Bio-tech Spółka z Ograniczoną Odpowiedzialnością w Upadłości